Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial

STUDY OBJECTIVES: Minimally symptomatic obstructive sleep apnea (OSA) is highly prevalent, and the effects of continuous positive airway pressure (CPAP) on myocardial function in these patients are unknown. The MOSAIC randomized, controlled trial of CPAP for minimally symptomatic OSA assessed the ef...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Craig, S, Kylintireas, I, Kohler, M, Nicoll, D, Bratton, D, Nunn, A, Leeson, P, Neubauer, S, Stradling, J
Format:	Journal article
Sprache:	English
Veröffentlicht:	American Academy of Sleep Medicine 2015

Ähnliche Einträge

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
von: Kohler, M, et al.
Veröffentlicht: (2013)

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL
von: Kohler, M, et al.
Veröffentlicht: (2010)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
von: Craig, S, et al.
Veröffentlicht: (2014)

Patterns of CPAP usage in patients with minimally symptomatic OSA
von: Turnbull, C, et al.
Veröffentlicht: (2015)

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?
von: Craig, SE, et al.
Veröffentlicht: (2010)

In minimally symptomatic OSA what is the best test to measure CPAP response?
von: Turnbull, C, et al.
Veröffentlicht: (2015)

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
von: Turnbull, CD, et al.
Veröffentlicht: (2016)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
von: Tang, I, et al.
Veröffentlicht: (2020)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
von: John R Stradling, et al.
Veröffentlicht: (2020-09-01)

Mild To Moderate, Minimally Symptomatic, Obstructive Sleep Apnoea (OSA) Is Associated With 'Vulnerable' Carotid Atherosclerotic Plaques
von: Craig, SE, et al.
Veröffentlicht: (2010)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
von: Craig, SE, et al.
Veröffentlicht: (2012)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
von: Craig, SE, et al.
Veröffentlicht: (2012)

ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
von: Schlatzer, C, et al.
Veröffentlicht: (2016)

CPAP and measures of cardiovascular risk in males with OSAS.
von: Kohler, M, et al.
Veröffentlicht: (2008)

Residual sleepiness in patients with OSA on CPAP.
von: Stradling, JR
Veröffentlicht: (2009)

Predictors of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial.
von: Turnbull, C, et al.
Veröffentlicht: (2015)

Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea.
von: Kohler, M, et al.
Veröffentlicht: (2008)

Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
von: Bratton, D, et al.
Veröffentlicht: (2014)

The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
von: Turnbull, C, et al.
Veröffentlicht: (2016)

Right ventricular responses to CPAP therapy in obstructive sleep apnea: CMR analysis of the MOSAIC randomized trial
von: Chinthaka B. Samaranayake, et al.
Veröffentlicht: (2023-01-01)

Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
von: Antoniades, C, et al.
Veröffentlicht: (2016)

Relative accuracy of algorithm-based prescription of nasal CPAP in OSA.
von: Stradling, JR, et al.
Veröffentlicht: (2004)

A novel, simplified approach to starting nasal CPAP therapy in OSA.
von: Stradling, JR, et al.
Veröffentlicht: (2004)

Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
von: Lettau, F, et al.
Veröffentlicht: (2017)

Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
von: Schwarz, E, et al.
Veröffentlicht: (2016)

EFFECT OF CPAP TREATMENT FOR OSA ON VISUAL PROCESSING OF DEGRADED WORDS
von: Proudlove, K, et al.
Veröffentlicht: (2012)

Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
von: Schwarz, E, et al.
Veröffentlicht: (2016)

Baseline blood pressure and hypersomnolence predict bp fall with CPAP treatment of OSA
von: Robinson, G, et al.
Veröffentlicht: (2007)

Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
von: Ayers, L, et al.
Veröffentlicht: (2009)

Circulating Cell-Derived Microparticles in Patients with Minimally Symptomatic Obstructive Sleep Apnea
von: Kohler, M, et al.
Veröffentlicht: (2009)

Effects of Overnight Supplemental Oxygen on Morning Blood Pressure in a Randomized Controlled CPAP Withdrawal Trial in Patients with OSA
von: Petousi, N, et al.
Veröffentlicht: (2018)

Effect of CPAP on depressive symptoms in OSA
von: Samy S. Eldahdouh, et al.
Veröffentlicht: (2014-04-01)

Predictors Of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial
von: Turnbull, C, et al.
Veröffentlicht: (2015)

Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
von: Schulz, U, et al.
Veröffentlicht: (2013)

CPAP increases bronchial reactivity in OSAS patients
von: P. Korczyski, et al.
Veröffentlicht: (2008-06-01)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
von: Robinson, G, et al.
Veröffentlicht: (2008)

Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?
von: Turnbull, C, et al.
Veröffentlicht: (2015)

Metabolic Sydrome Prediction in Mild/Moderate OSA Patients - Anthropometric Measures and Abdominal Fat Estimations by MRI
von: Craig, SE, et al.
Veröffentlicht: (2009)

EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) ON DIURNAL SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA (OSA)
von: Warley, A, et al.
Veröffentlicht: (1987)

Cardiovascular event rates in the MOSAIC trial: 2-year follow-up data.
von: Turnbull, C, et al.
Veröffentlicht: (2014)